Today, drug makers - including Johnson & Johnson, Wyeth and Novartis -. The move came less than two weeks after the U.S. government warned of potential health risks to infants.
Products aimed at children under the age of 2 are being removed from store shelves due to "rare instances of misuse" that could lead to accidental overdose, a trade group that represents over-the-counter drug makers said.
Which medications have been recalled?
Over the counter branded pediatric cough and cold medicines affected by this voluntary withdrawal include:For images of these products, click here.
Dimetapp® Decongestant Plus Cough Infant Drops Dimetapp® Decongestant Infant Drops Little Colds® Decongestant Plus Cough Little Colds® Multi-Symptom Cold Formula PEDIACARE® Infant Drops Decongestant (containing pseudoephedrine) PEDIACARE® Infant Drops Decongestant & Cough (containing pseudoephedrine) PEDIACARE® Infant Dropper Decongestant (containing phenylephrine) PEDIACARE® Infant Dropper Long-Acting Cough PEDIACARE® Infant Dropper Decongestant & Cough (containing phenylephrine) Robitussin® Infant Cough DM Drops Triaminic® Infant & Toddler Thin Strips® Decongestant Triaminic® Infant & Toddler Thin Strips® Decongestant Plus Cough TYLENOL® Concentrated Infants' Drops Plus Cold TYLENOL® Concentrated Infants' Drops Plus Cold & Cough
For more information:
Visit the Over-the-counter safety Web site by the Consumer Healthcare Products Association. Read today's information release by the CHPA. Check out the U.S. Food and Drug Administration's tip-sheet, "Kids aren't Just Small Adults".